The aim of our study was to assess university students’ sleep quality and fatigue before and during the academic exam period and identify potential associated factors. A Web-based survey was completed by 940 students of 20 different Tertiary Institutions including demographics, sleep habits, exercise, caffeine, tobacco, alcohol use, subjective sleep quality (Pittsburgh Sleep Quality Index—PSQI), and fatigue (Fatigue severity scale—FSS) at the beginning of the semester and during the examination period. During the exam period, PSQI (8.9 vs. 6.1, p < 0.001) and FSS scores (36.9 vs. 32.7, p < 0.001) were significantly elevated compared to the pre-exam period. An increase in the PSQI score was associated with age (β = 0.111, p = 0.011), presence of chronic disease (β = 0.914, p = 0.006), and depressive symptoms (β = 0.459, p = 0.001). An increase in the FSS score was associated with female gender (β = 1.658, p < 0.001), age, (β = 0.198, p = 0.010), increase in smoking (β = 1.7, p = 0.029), coffee/energy drinks consumption (β = 1.988, p < 0.001), decreased levels of physical exercise (β = 1.660, p < 0.001), and depressive symptoms (β = 2.526, p < 0.001). In conclusion, our findings indicate that exam periods have a negative impact on the sleep quality and fatigue levels of university students. Potential factors were identified that could contribute to the formulation of strategies for improved sleep quality and wellness.

During the current pandemic, we witnessed a rise of post-intubation tracheal stenosis (PITS) in patients intubated due to COVID-19. We prospectively analyzed data from patients referred to our institution during the last 18 months for severe symptomatic post-intubation upper airway complications. Interdisciplinary bronchoscopic and/or surgical management was offered. Twenty-three patients with PITS and/or tracheoesophageal fistulae were included. They had undergone 31.85 (±22.7) days of ICU hospitalization and 17.35 (±7.4) days of intubation. Tracheal stenoses were mostly complex, located in the subglottic or mid-tracheal area. A total of 83% of patients had fracture and distortion of the tracheal wall. Fifteen patients were initially treated with rigid bronchoscopic modalities and/or stent placement and eight patients with tracheal resection-anastomosis. Post-treatment relapse in two of the bronchoscopically treated patients required surgery, while two of the surgically treated patients required rigid bronchoscopy and stent placement. Transient, non-life-threatening post-treatment complications developed in 60% of patients and were all managed successfully. The histopathology of the resected tracheal specimens didn’t reveal specific alterations in comparison to pre-COVID-era PITS cases. Prolonged intubation, pronation maneuvers, oversized tubes or cuffs, and patient- or disease-specific factors may be pathogenically implicated. An increase of post-COVID PITS is anticipated. Careful prevention, early detection and effective management of these iatrogenic complications are warranted.

Background: Lung Cancer Screening (LCS) is an evolving field with variations in its implementation in various countries. There are only scarce data from National LCS programs. Aim: We aim to provide an up-to-date overview of the current evidence regarding the use of biomarkers in LCS. Materials and Methods: A multidisciplinary Task Force experts’ panel collaborated and conducted a systematic literature search, followed by screening, review and synthesis of available evidence. Results: Biomarkers in LCS could be used to improve risk stratification in high-risk participants, improve clarification regarding indeterminate lung nodules and avoid overdiagnosis in suspicious lung findings. Currently, there seem to be promising biomarkers (blood/serum/breath) that have been studied in various trials; however, there is still a lack of solid evidence in clinical validation that would pave the way for their integration into LCS programs. Conclusions: Biomarkers are the next logical step in improving the LCS pathway and its efficiency by playing an adjuvant role in a minimally invasive way. National LCS programs and pilot studies should integrate biomarkers to validate their accuracy in real-life LCS participants.

The aim of our study was to assess university students’ sleep quality and fatigue before and during the academic exam period and identify potential associated factors. A Web-based survey was completed by 940 students of 20 different Tertiary Institutions including demographics, sleep habits, exercise, caffeine, tobacco, alcohol use, subjective sleep quality (Pittsburgh Sleep Quality Index - PSQI) and fatigue (Fatigue severity scale – FSS) at the beginning of semester and at examination period. During exam period, PSQI (8.9 vs 6.1, p<0.001) and FSS scores (36.9 vs 32.7, p<0.001) were significantly elevated compared to pre-exam period. Increase of PSQI score was associated with age (β=0.111, p=0.011), presence of chronic disease (β=0.914, p=0.006), and depressive symptoms (β=0.459, p=0.001). Increase of FSS score was associated with female gender (β=1.658, p<0.001), age, (β=0.198, p=0.010), increase in smoking (β=1.7, p=0.029), coffee/energy drinks consumption (β=1.988, p<0.001), decreased levels of physical exercise (β=1.660, p<0.001), and depressive symptoms (β=2.526, p<0.001). In conclusion, our results show that sleep quality and fatigue are affected in university students during exam periods. Potential factors were identified which may lead to development of strategies for better quality of sleep, and wellbeing.

Endobronchial ultrasound (EBUS) has evolved beyond conventional applications in mediastinal staging and central pulmonary tumor diagnosis. It encompasses the assessment of pulmonary vasculature in patients with thoracic malignancies. EBUS can visualize major vessels and allow assessment of pulmonary embolism, differential diagnosis of endovascular lesions, and T staging. Additionally, EBUS-guided transvascular needle aspiration (TVNA) has proven valuable for sampling lesions behind vessels and diagnosing conditions such as pulmonary artery sarcoma and tumor embolism, with low complication rates reported. The PubMed and SCOPUS databases were searched up to November 2024 for articles in the English language reporting the use of EBUS for pulmonary vasculature assessment. References were also searched for relevant articles. The integration of EBUS with other modalities enhances staging and diagnostic capabilities in thoracic malignancies. Despite promising findings, limitations include suboptimal image quality and challenges in extensively assessing all the vasculature. Safety concerns, particularly with transvascular biopsy, remain minimal with expert handling, although further studies are needed to assess specific risks like hematogenous tumor seeding. EBUS continues to evolve, suggesting its potential to become the cornerstone in advanced thoracic diagnostics and treatment planning. This review systematically explores the feasibility, safety, and diagnostic utility of EBUS in pulmonary vasculature assessment, highlighting its potential as an indispensable tool in thoracic diagnostics and treatment planning.

Introduction: Obstructive sleep apnea (OSA) patients undergoing procedures under sedation may have increased tendency for respiratory failure and hypoxemia. The aim of our study was to investigate if screening for OSA can be used to detect high risk patients for desaturations and apneas during the bronchoscopy and whether non-invasive mechanical ventilation (NIMV) could be used to improve oxygenation and reduce peri- and post- bronchoscopy complications. Methods: This is a prospective, single-center study performed in our Institution. Patients undergoing bronchoscopy were recruited. Those with Stop Bang Score ≥4 and/or Epworth Sleepiness scale (ESS) ≥11 were categorized as high-risk patients for OSA and randomized to receive either NIMV or nasal cannula oxygenation during bronchoscopy. Low risk patients (Stop Bang Score <4 and/or ESS<11) received with nasal cannula oxygenation. Results: A total of 56 patients (33 males), with a median age of 65.5 years old and a median BMI of 27 kg/m2 were included. Witnessed apneas, excessive dynamic airway collapse (EDAC) episodes and airway maneuvers during the bronchoscopy were significantly more in high-risk patients compared to low-risk patients (81.8% vs 41.1%, 72.2% vs 35.2%, 72.7% vs 26.4% p<0.05, respectively). NIMV use reduced witnessed apneas, desaturations and EDAC (18.1% vs 81.8%, 36.3% vs 81.8%, 9% vs 92.2% p<0.05 respectively). Conclusions: Screening for sleep apnea, with these well-established questionnaires could be a helpful addition to the standard pre-bronchoscopy evaluation. Moreover, bronchoscopy under NIMV may be considered when high risk patients for OSA are identified in pre-bronchoscopy evaluation.